Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial

Ken Ohmachi, Kensei Tobinai, Tomohiro Kinoshita, Takayuki Ishikawa, Kiyohiko Hatake, Satoshi Ichikawa, Ken Ohmine, Yuri Kamitsuji, Ilseung Choi, Takaaki Chou, Kunihiro Tsukasaki, Kyoya Kumagai, Masafumi Taniwaki, Toshiki Uchida, Yoshitaka Kikukawa, Kohmei Kubo, Keichiro Mihara, Norifumi Tsukamoto, Koji Izutsu, Isao YoshidaFumihiro Ishida, Noriko Usui, Shinsuke Iida, Tohru Murayama, Eisuke Ueda, Hiroshi Kuriki, Kiyoshi Ando

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial'. Together they form a unique fingerprint.

Medicine & Life Sciences